CVS CFO Shawn Guertin takes leave; Tom Cowhey named interim CFO; Mike Pykosz interim Health Svcs Pres

CVS HEALTH Corp

Guertin's leave effective immediately for unforeseen family medical reasons; Cowhey (SVP Corporate Finance) appointed interim CFO.
Mike Pykosz, CEO of Oak Street Health, named interim President of Health Services, assuming Guertin's dual role.
FY2023 GAAP EPS guidance reaffirmed at $6.53-$6.75; Adjusted EPS reaffirmed at $8.50-$8.70.
Q3 earnings call remains Nov 1, 2023; Investor Day remains Dec 5, 2023, as previously scheduled.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Shawn M. Guertin

Executive Vice President and Chief Financial Officer

CVS · CVS HEALTH Corp

Effective: 2023-10-13
Successor: Thomas F. Cowhey
Filed: October 16, 2023, 7:59 PM ET

Effective October 13, 2023, Shawn M. Guertin, the Executive Vice President and Chief Financial Officer of CVS Health Corporation (“CVS Health,” the “Company,” “we” or “our”), has begun a personal leave of absence for unforeseen family medical reasons.

Appointed (interim)

Thomas F. Cowhey

Interim Chief Financial Officer

CVS · CVS HEALTH Corp

Effective: 2023-10-13
Filed: October 16, 2023, 7:59 PM ET

Appointment of Interim Chief Financial Officer In connection with Mr. Guertin’s leave, the Company’s Board of Directors appointed Thomas F. Cowhey, Senior Vice President, Corporate Finance, to serve as the Company’s Interim Chief Financial Officer, effective October 13, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shawn M. Guertin departed as Executive Vice President and Chief Financial Officer at CVS HEALTH Corp.

Action: began a personal leave of absence
Role: Executive Vice President and Chief Financial Officer

Exact text from the filing

Effective October 13, 2023, Shawn M. Guertin, the Executive Vice President and Chief Financial Officer of CVS Health Corporation (“CVS Health,” the “Company,” “we” or “our”), has begun a personal leave of absence for unforeseen family medical reasons.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas F. Cowhey was appointed as Interim Chief Financial Officer at CVS HEALTH Corp.

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

Appointment of Interim Chief Financial Officer In connection with Mr. Guertin’s leave, the Company’s Board of Directors appointed Thomas F. Cowhey, Senior Vice President, Corporate Finance, to serve as the Company’s Interim Chief Financial Officer, effective October 13, 2023.

View on SEC.gov

CVS HEALTH Corp filing history →

Source: SEC EDGAR

accession 0000947871-23-000994

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.